Excited to welcome @styxbio to Portal! Styx was founded in San Diego & their technology allows specific reprogramming of immune cells to generate more enduring immune responses to combat diseases. Great to have you with us, @styxbio &
@AshimaBhakri!
Styx Biotech is being featured in #FIVETENTHIRTY as #coolco22. Come and visit us (@AshimaBhakri@emailtoashu, Anindya Bagchi) and see how we are transforming immunotherapy and vaccines for better human health!
The Class of 2022 Cool Companies is here! Come check out our list of 43 #tech and #lifesci companies that were selected to be a part of our annual capital program. Have a chance to meet them in-person at #FIVETENTHIRTY
See The Full List: https://t.co/w8Pb1WBSSt
Styx Biotechnologies is proud to be among the select five Southern California-based therapeutic startups being featured in the signature annual SDIC showcase event!
https://t.co/4CvuOJzAjX #GoDaddy#Email#Marketing via @GoDaddy
Styx Biotechnologies is proud to be among the select five Southern California-based therapeutic startups being featured in the signature annual SDIC showcase event! https://t.co/4CvuOJzAjX #GoDaddy#Email#Marketing via @GoDaddy
Congrats to @styxbio, a startup formed by Sanford Burnham Prebys scientists who are working to develop better vaccines. Styx is a finalist in the @SDInnovCouncil’s “Inventors and Investors” startup competition held on Oct. 9: https://t.co/r3ccvR5gg8 #SDSM2020@StartUpSanDiego
Congratulations, to Dr.@TannishthaReya from Styx team on receiving Frederick W. Alt Award for her enormous contribution in Cancer Field. @CancerResearch
Former CRI postdoctoral fellow Dr. @TannishthaReya of @UCSanDiego will receive the Frederick W. Alt Award in recognition of her work on the mechanisms that regulate stem cell fate and self-renewal and dysregulated in cancer. https://t.co/RCaGrSWYTA #CRIawards
Former CRI postdoctoral fellow Dr. @TannishthaReya of @UCSanDiego will receive the Frederick W. Alt Award in recognition of her work on the mechanisms that regulate stem cell fate and self-renewal and dysregulated in cancer. https://t.co/RCaGrSWYTA #CRIawards
“Our hypothesis was that if we remove HIF1A…growth should be delayed or we should be curing the cancer. Instead, we got the exact opposite results.” Read how a surprising finding revealed a new drug target for deadly #PancreaticCancer: https://t.co/hOEUzmpJnd @PanCAN@AGA_Gastro
The new findings are from an extended follow-up of the NCI-sponsored Costa Rica #HPV Vaccine Trial: https://t.co/BiGD6vixPq @NCIEpiTraining #HPVvaccine
Here’s a 3D print of a SARS-CoV-2—also known as 2019-nCoV, the virus that causes #COVID19—virus particle. The virus surface (blue) is covered with spike proteins (red) that enable the virus to enter and infect human cells. #coronavirus
FOR IMMEDIATE RELEASE & USAGE: "A Massively Parallel COVID-19 Diagnostic Assay for Simultaneous Testing of 19200 Patient Samples" Protocol at https://t.co/x2c2v8uvw3. Primers & Spike-in Controls at https://t.co/9cWzQrfz5P
For the hardworking researchers out there, 🙏🏼and please have some data: Microsoft, White House, and Allen Institute release coronavirus data set for medical and NLP researchers
https://t.co/KZsKE0CWBC via @VentureBeat